MUSSO, Giovanni
 Distribuzione geografica
Continente #
AS - Asia 1.805
NA - Nord America 1.460
EU - Europa 1.233
SA - Sud America 368
OC - Oceania 49
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 4
Totale 4.947
Nazione #
US - Stati Uniti d'America 1.160
CN - Cina 999
JP - Giappone 284
IT - Italia 256
MX - Messico 216
DE - Germania 137
GB - Regno Unito 118
FR - Francia 114
BR - Brasile 107
ES - Italia 107
SG - Singapore 87
SE - Svezia 75
IN - India 72
CO - Colombia 64
KR - Corea 58
PE - Perù 58
IE - Irlanda 57
CA - Canada 53
EC - Ecuador 51
TR - Turchia 51
TW - Taiwan 47
ID - Indonesia 46
AU - Australia 45
CL - Cile 38
VN - Vietnam 36
AR - Argentina 34
GR - Grecia 32
FI - Finlandia 31
AT - Austria 30
PL - Polonia 29
NL - Olanda 26
CH - Svizzera 25
PT - Portogallo 25
RU - Federazione Russa 25
BE - Belgio 22
DK - Danimarca 21
UA - Ucraina 21
HK - Hong Kong 19
CZ - Repubblica Ceca 17
RO - Romania 15
TH - Thailandia 14
GT - Guatemala 12
SI - Slovenia 11
HU - Ungheria 10
IR - Iran 10
PH - Filippine 10
VE - Venezuela 10
IL - Israele 9
MY - Malesia 8
MM - Myanmar 7
HN - Honduras 6
QA - Qatar 6
RS - Serbia 6
AZ - Azerbaigian 5
CR - Costa Rica 5
LB - Libano 5
LV - Lettonia 5
NO - Norvegia 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
SY - Repubblica araba siriana 4
ZA - Sudafrica 4
BA - Bosnia-Erzegovina 3
BF - Burkina Faso 3
BO - Bolivia 3
CV - Capo Verde 3
EU - Europa 3
HR - Croazia 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
LK - Sri Lanka 3
NI - Nicaragua 3
UY - Uruguay 3
BY - Bielorussia 2
CD - Congo 2
DZ - Algeria 2
EG - Egitto 2
GH - Ghana 2
IQ - Iraq 2
MO - Macao, regione amministrativa speciale della Cina 2
PA - Panama 2
SV - El Salvador 2
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
KW - Kuwait 1
LU - Lussemburgo 1
NG - Nigeria 1
RE - Reunion 1
RW - Ruanda 1
UZ - Uzbekistan 1
Totale 4.947
Città #
Beijing 142
Redwood City 124
Chandler 117
Shanghai 97
Guangzhou 73
Tokyo 73
Singapore 59
Nanjing 57
Dublin 54
Ashburn 52
Torino 46
Ann Arbor 44
Fairfield 41
Hangzhou 41
Houston 37
Wuhan 36
Shenyang 35
Lima 33
Santa Clara 31
Chengdu 29
Chongqing 27
Santiago 27
Taipei 26
Turin 26
Bogotá 25
Woodbridge 25
Cambridge 24
Milan 24
São Paulo 24
London 23
Nyköping 23
Rome 23
Mexico City 20
Vienna 20
Wilmington 20
Istanbul 19
Seattle 19
Tianjin 18
Glasgow 17
Guayaquil 17
Jakarta 17
Medford 17
Columbus 16
Helsinki 16
Villeurbanne 16
Buenos Aires 15
Hefei 15
Jacksonville 15
Mexico 15
Osaka 15
Changsha 14
Guadalajara 14
Jinan 14
Ottawa 14
Seoul 14
Barcelona 13
Boardman 13
Princeton 13
Berlin 12
Changchun 12
Dearborn 12
Fuzhou 12
Dong Ket 11
Guatemala City 11
Monterrey 11
Arequipa 10
Caruaru 10
Cuenca 10
Paris 10
Quito 10
San Diego 10
Zurich 10
Athens 9
Bangkok 9
Belo Horizonte 9
Brisbane 9
Duncan 9
Frankfurt am Main 9
Hyderabad 9
Xian 9
Zhengzhou 9
Chennai 8
Louisville 8
Mumbai 8
Saint Louis 8
Santo Domingo de los Colorados 8
Thessaloniki 8
Ankara 7
Boston 7
Chicago 7
Fremont 7
Guiyang 7
Kunming 7
Los Angeles 7
Manilva 7
Nanchang 7
Prague 7
Yangon 7
Central District 6
Doha 6
Totale 2.303
Nome #
Diabetic ketoacidosis with SGLT2 inhibitors 2.475
Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis 905
Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation 430
Specialized Proresolving Mediators: Enhancing Nonalcoholic Steatohepatitis and Fibrosis Resolution 280
Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials 194
Targeting mitochondrial pyruvate carrier in nonalcoholic steatohepatitis: Growing evidence and future challenges. 141
Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma 123
Emerging Liver-Kidney Interactions in Nonalcoholic Fatty Liver Disease 97
Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies 94
MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes Role of mononuclear cell activation and adipokine response to dietary fat 80
Letter by Musso et al Regarding Article, "Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus" 73
TM6SF2 may drive postprandial cholesterol toxicity away from the vessel walls to the liver in NAFLD 68
Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression 64
Endoscopic duodenal mucosa ablation techniques for diabetes and nonalcoholic fatty liver disease: A systematic review 18
Effect of phospholipid curcumin Meriva® on liver histology and kidney disease in nonalcoholic steatohepatitis a randomized, double-blind, placebo-controlled trial 15
Endoscopic duodenal mucosa ablation: the future of diabetes treatment? 10
Totale 5.067
Categoria #
all - tutte 9.278
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.278


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020437 0 0 0 0 9 41 63 60 66 90 48 60
2020/2021698 23 53 39 42 42 64 54 40 71 82 86 102
2021/20221.123 61 100 93 105 106 82 133 96 95 58 106 88
2022/2023848 47 88 29 72 58 117 77 63 66 56 90 85
2023/20241.172 107 136 109 109 104 104 110 84 26 97 113 73
2024/2025584 111 103 125 92 153 0 0 0 0 0 0 0
Totale 5.067